Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-24

Clinical Trial Update: Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating repetitive transcranial magnetic stimulation for depersonalization disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Depersonalization Disorder | Phase 2 | Status: WITHDRAWN